openPR Logo
Press release

Peptide Based Cancer Therapeutics Market To Surpass A Valuation of US$ 11,100 Mn by 2022

04-15-2021 11:29 PM CET | Health & Medicine

Press release from: Fact.MR

Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug modification, stability, delivery and preclinical achievements is reflecting positively on the future prospects of the global peptide based cancer therapeutics market.


Of late, an array of new peptides with encouraging preclinical results are undergoing clinical trials for treating cancer. At the same time, these new peptide are also finding application in various other therapeutic areas. Also, increasing occurrence of cancer is anticipated to be instrumental in boosting the demand for peptide based cancer therapeutics in the near future.

To get in-depth information view the report @https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market

As per WHO, over 8 million deaths were recorder globally due to cancer in 2015. Cancer remains one of the foremost causes of death around the world. Factors mentioned above are projected to make a significant influence on the global market for peptide based cancer therapeutics over the forecast period.

Moreover, low potency of conventional cancer therapeutics and the adverse side-effects from these therapeutics is prompting physicians to utilise other options. This, in turn, is facilitating the adoption of new-age peptide based therapeutic drugs.

For more insights into the Market, Request a Sample of this Report @https://www.factmr.com/connectus/sample?flag=S&rep_id=179

Forecast Highlights Of Global Market For Peptide Based Cancer Therapeutics

Among regions, North America is expected to remain the most attractive market for peptide based cancer therapeutics during the forecast period. This is largely due to the existence of several prominent peptide based cancer therapeutic drug makers and an advanced healthcare infrastructure in the region.

Over the next couple of years, the region’s market is projected to witness a healthy growth. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) is anticipated to register the fastest CAGR over 2022.

Access Research Methodology Prepared By Experts @https://www.factmr.com/connectus/sample?flag=RM&rep_id=179

Based on drugs, demand for bortezomib is expected to remain relative higher as compared to other peptide based cancer therapeutic drugs. Revenues from global sales of bortezomib drugs currently commands for nearly 40% market share. Towards the end of 2022, more than US$ 4,700 Mn worth bortezomib drugs are estimated to be sold worldwide.
Hospital pharmacies are the largest distribution channel for peptide based cancer therapeutic drugs followed by retail pharmacies. Currently, hospital pharmacies account for close to 50% share of the global market in terms of revenue. The trend is likely to continue in 2017 and beyond.
Competition Tracking

To get in-depth insights on the regional landscape of the market, ask an analyst here @https://www.factmr.com/connectus/sample?flag=AE&rep_id=179

Valeant Pharmaceuticals International, Inc., Allergan plc, AbbVie Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Abbott, Pfizer Inc., and Johnson & Johnson are among the leading companies functioning in the global market for peptide based cancer therapeutics. Majority of these market players are actively focusing on further product development as well as channelizing their investments in R&D activities.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com

Research Insight: https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market
Content Source: https://www.factmr.com/media-release/169/peptide-based-cancer-therapeutics-market

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Based Cancer Therapeutics Market To Surpass A Valuation of US$ 11,100 Mn by 2022 here

News-ID: 2271126 • Views:

More Releases from Fact.MR

Organic Rice Syrup Market is forecasted to increase at a CAGR of 5.1% and US$ 1.36 billion by 2034
02-27-2026 | Food & Beverage
Fact.MR
Organic Rice Syrup Market is forecasted to increase at a CAGR of 5.1% and US$ 1. …
The global Organic Rice Syrup Market is projected to expand steadily over the coming decade, driven by rising consumer demand for natural, clean-label sweeteners and growing awareness of health and wellness trends. Industry analysts estimate that the organic rice syrup market, valued at approximately USD 450 million in 2025, is expected to reach nearly USD 880 million by 2035, registering a compound annual growth rate (CAGR) of about 7.1% during
Compound Horse Feedstuff Market is Estimated to Grow at a CAGR of 4.6%, Reaching USD 13.9 billion by 2035
02-27-2026 | Food & Beverage
Fact.MR
Compound Horse Feedstuff Market is Estimated to Grow at a CAGR of 4.6%, Reaching …
The global compound horse feedstuff market is galloping toward steady growth, projected to expand from a valuation of USD 3.8 billion in 2026 to approximately USD 5.4 billion by 2036. This represents a compound annual growth rate (CAGR) of 3.6% over the ten-year forecast period. The market is being driven by the "humanization" of equine companions, the professionalization of equestrian sports, and a significant shift toward specialized performance nutrition that
Nutritional Yeast Market Forecasted CAGR is 7.1% by 2035 | Fact.MR Report
02-27-2026 | Food & Beverage
Fact.MR
Nutritional Yeast Market Forecasted CAGR is 7.1% by 2035 | Fact.MR Report
The global nutritional yeast market is experiencing a significant surge in demand, projected to grow from a valuation of USD 515.2 million in 2026 to approximately USD 1.2 billion by 2036. This represents a robust compound annual growth rate (CAGR) of 8.8% over the ten-year forecast period. The market is being propelled by the global explosion of plant-based diets and the "clean-label" movement, with nutritional yeast emerging as the primary
Dairy Stabilizer Market is Expected to Reach USD 1,420.0 million by 2035 | Research Report by Fact.MR
02-27-2026 | Food & Beverage
Fact.MR
Dairy Stabilizer Market is Expected to Reach USD 1,420.0 million by 2035 | Resea …
The global Dairy Stabilizers Market is projected to sustain solid growth over the next decade as consumer demand for high-quality dairy and dairy-based products continues to expand across foodservice and retail sectors. Industry analysts estimate that the dairy stabilizers market, valued at approximately USD 2.4 billion in 2025, is expected to reach around USD 4.3 billion by 2035, registering a compound annual growth rate (CAGR) of about 6.5% during the

All 5 Releases


More Releases for Unit

Global Transcutaneous Electrical Nerve Stimulation Unit Market, Transcutaneous E …
Global Transcutaneous Electrical Nerve Stimulation Unit Market Overview: The Transcutaneous Electrical Nerve Stimulation Unit market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Transcutaneous Electrical Nerve Stimulation Unit market has experienced significant growth, driven by factors such as increasing consumer demand,
Glycol Dehydration Unit Market Glycol Dehydration Unit Market 2028
Persistence Market Research delivers key insights on the global glycol dehydration unit market, in its report titled, 'Glycol Dehydration Unit Market: Global Industry Analysis 2013-2017 and Forecast 2018-2028'. Over the forecast years, the global glycol dehydration unit market is expected to show a positive outlook. The market value is expected to increase at a healthy pace over the forecast period. Based on the glycol type segment, the triethylene glycol segment is
Biodiesel Processing Unit
While reserves of petroleum are decreasing every passing day, energy consumption is increasing at 6.5% per annum. And for solving this issue many countries are implementing new policies for minimizing the usage of fossil fuels and increase the use of alternative sources like solar power and Biodiesel. Biodiesel is a diesel fuel substitute made from a variety of oils, fats, and greases which can become a cheaper alternative to fossil
Jackfruit Processing Unit
The fruit processing sector has some undoubtedly potential Business Ideas, and Jackfruits processing is highly recommended because jackfruits are highly perishable tropical fruits, which helps in improving the immunity, replenishes the energy, cardiovascular health, regulates Blood Pressure, Digestion, treats the skin diseases, prevent/control asthma and many more awesome advantages of jackfruit consumption. Rising demand for processed fruit product for secondary preparations, rising income, and resultant increased spending on food items is
Pomegranate Processing unit
India is the second largest producer of Pomegranates in the world after Iran, still contributes only 5% pomegranate related international trades. India produces the finest edible Pomegranates, which are available almost throughout the year, which provides a tremendous potential for export of Pomegranate and its products from India. Processing of the Pomegranates becomes essential in order to increase the utilization and reduce the wastage of the fruit. Pomegranates being rich in
Coconut Processing Unit
Coconut is an important fruit in the Indian economy as the country is listed among the top Coconut producing countries in the world. The contribution of Coconut is about ₹27900 crore to India’s Gross Domestic Product (GDP). Today's improved economic stability, spending power, nutritional requirements, and awareness are pushing consumers to shift their preferences. Currently, Coconut water, Coconut milk/cream and Virgin Coconut Oil (VCO) are expected to be main growth drivers for